Affecting 30 million people, most #rarediseases do not have approved treatments. The FDA plans to establish an Innovation Hub to enhance the development of new therapies – learn more: https://bit.ly/3Y50bPn
Premier Research
Biotechnology Research
Morrisville, NC 122,781 followers
We’re Built for Biotech℠, dedicated to helping today’s top innovators turn big ideas into life-changing treatments.
About us
We’re out to change the course of medical science. Are you ready to rise to the challenge? Premier Research is not about being everything to everyone. Instead, our deep, focused expertise targets the therapeutic areas and indications where today’s biotech and specialty pharma pioneers are doing the most amazing work. We’re 2,500 employees strong operating directly and via CRO partners across 75 countries to deliver unmatched expertise, operational skills, and dedication to meeting customers’ most challenging needs. Join us and meet some of the brightest minds in clinical development today — people who apply their best thinking to every project, recognizing that what they do significantly affects the lives and well-being of customers, patients, physicians, and colleagues. You’ll enjoy great benefits and very flexible working conditions in a company that values your contributions, rewards your achievements, and is committed to helping you reach your full potential. Are you ready to make a real difference and help us transform this exciting industry? Follow our company page for more information about us and the work we do, and check out our current openings for your next career move!
- Website
-
http://www.premier-research.com
External link for Premier Research
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Morrisville, NC
- Type
- Privately Held
- Founded
- 1989
- Specialties
- Analgesia, CNS/Neuroscience, Rare Disease, Pediatrics, Oncology, Clinical Development Services, Medical Device, Dermatology, Women's Health, and Diagnostics
Locations
-
Primary
3800 Paramount Parkway
Suite 400
Morrisville, NC 27560, US
-
1st floor, Rubra 2
Mulberry Business Park, Fishponds Road
Wokingham, RG41 2GY, GB
Employees at Premier Research
Updates
-
Patient-centered trials don’t just benefit participants – sponsors can also gain a competitive edge! Here’s how to approach design, recruitment, and implementation in #dermatology studies: https://bit.ly/3NyeOmp #PatientCentricity #PatientsFirst #DermatologyClinicalTrials #ClinicalResearch
-
For many, #depression can be hard to speak about, especially when so many treatments just aren’t enough. We know how important it is to develop and bring more effective drugs to market globally: https://bit.ly/4bVnWMQ #AntidepressantMarket #DrugDevelopment #FDA #EMA
-
Join us at the upcoming #OCRA Annual Conference on August 2 and listen to Abie Ekangaki, PhD discuss how #insilico methods can help accelerate drug development! https://bit.ly/3LBtrpe
-
Flexible, efficient, and informative, adaptive design in #clinicaltrials can reduce costs, time, and resources when bringing new therapies to market. Interested? Explore these benefits and more: https://bit.ly/44ob5AK #ClinicalResearch #AdaptiveDesign #DrugDevelopment #DoseEscalationStudies
-
CAR-T therapies present unique challenges. However, opportunities for CAR-T in solid tumors remain and the research is growing! Join the journey as we explore both limitations and progress: https://bit.ly/43JYbf1 #CARTcelltherapies #Oncology #CancerResearch #ClinicalResearch
-
The demand for diagnostic services is apparent, and as participation in clinical trials grows, it is crucial to approach diagnostic clinical trials with meticulous care and planning. Learn how: https://bit.ly/3ScKlOL #DiagnosticTesting #DiagnosticClinicalTrials #DiagnosticTrials #ClinicalTrials
-
Neurological disorders often lead to the loss of neurons. Now, researchers have discovered how glial cells can be reprogrammed into neurons - potentially leading to new therapies! https://bit.ly/3zQR3na #Neuroscience #Neurology
-
CNS conditions affect millions across the globe – despite a high failure rate, neuroscience trials remain critical for therapeutic development. Here are 7 strategies to increase success: https://lnkd.in/ePJdJP_9 #Neuroscience #ClinicalTrials #ClinicalDevelopment #RiskReduction
-
Check out ACRO's latest podcast episode to learn more about the impact that ICH E6(R3) will have on Good Clinical Practice - featuring Nicole Stansbury! #ICHE6R3 #GCP #GoodClinicalPractice #ClinicalResearch
“We can’t operate in an environment of fear. That can’t be the driving influence in how we behave and how we administer clinical trials. I think one of the things that we need to be afraid of is that we’ll be seen as an industry that’s not serving patients and physicians as well as we could.” In the latest episode of ACRO’s Good Clinical Podcast, “ICH E6 (R3): The Thinking Person’s GCP”, Nicole Stansbury, SVP, Global Clinical Operations, Premier Research and Madeleine Whitehead, RBQM Product & People Lead, TransCelerate BioPharma Inc., Roche, discuss the impact that ICH E6(R3) will have on Good Clinical Practice and implications for innovation. Listen to the full episode: https://lnkd.in/gdMz_agR